Back to UBS Group AG UBS Group AG

SLNSLN
21 quarters

Position history for UBS Group AGUBS Group AG's holdings in SILENCE THERAPEUTICS PLC

UBS Group AG holds 243,152 shares of SLN (SILENCE THERAPEUTICS PLC), worth $2.7M as of 2026-Q2. The position was decreased (-1.5% shares). SLN represents 0.0% of UBS Group AG's portfolio.

Current Value

$2.7M

Current Shares

243,152

Total Value Change

+$2.7M

Total Shares Change

+243,059

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
243,152
-1.5%
$2.7M0.0%$10.98
0
2026-Q1
Increased
246,937
+19.0%
$1.3M0.0%$5.66
30
2025-Q4
Decreased
207,513
-32.5%
$1.3M0.0%$6.15
0
2025-Q3
Increased
307,363
+34.5%
$1.6M0.0%$5.67
33
2025-Q2
Decreased
228,509
-28.5%
$1.3M0.0%$5.79
0
2025-Q1
Decreased
319,514
-10.3%
$901,0290.0%$3.44
0
2024-Q4
Increased
356,071
+403.9%
$2.4M0.0%$6.91
42
2024-Q3
Decreased
70,661
-4.3%
$1.3M0.0%$18.25
0
2024-Q2
Increased
73,806
+2.6%
$1.4M0.0%$19.00
26
2024-Q1
Increased
71,918
+2.8%
$1.6M0.0%$21.60
26
2023-Q4
Increased
69,946
+1.2%
$1.2M0.0%$17.37
26
2023-Q3
Decreased
69,113
-1.4%
$678,6900.0%$9.82
0
2023-Q2
Increased
70,130
+1.6%
$385,7150.0%$5.81
24
2023-Q1
Unchanged
69,006
0.0%
$427,8370.0%$6.30
0
2022-Q4
Increased
69,006
+4.8%
$1.1M0.0%$15.25
26
2022-Q3
Decreased
65,815
-5.0%
$660,0000.0%$10.00
0
2022-Q2
Decreased
69,255
-0.2%
$821,0000.0%$12.81
0
2022-Q1
Decreased
69,368
-1.2%
$1.3M0.0%$19.48
0
2021-Q4
New
70,218
-
$1.7M0.0%$24.00
36
2021-Q1
Exited
0
-100.0%
$00.0%$22.95
0
2020-Q4
New
93
-
$2,0000.0%$21.88
17

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used